Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 1 day ago

      Merck said that it is acquiring Eyebiotech (EyeBio) for $3 billion, as the company tries to diversify beyond its best-selling cancer drug Keytruda ...

    • Subtle victory for Sanders in Novo spat

      Politico· 1 day ago

      The FDA approved Merck’s Keytruda with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adults with primary advanced or recurrent endometrial

    • FDA Roundup: June 18, 2024

      The Woonsocket Call· 1 day ago

      Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA ...